Sernova Biotherapeutics (HAM:PSH0) ROCE %: 0.00% (As of Apr. 2026)


HAM:PSH0 Sernova Biotherapeutics Inc HAM:PSH0
28 GF Score
Price €0.05
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics ROCE %?

Sernova Biotherapeutics HAM:PSH0 -22.00% 28 ROCE % is 0.00% as of Apr. 2026. GuruFocus rates HAM:PSH0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sernova Biotherapeutics's annualized ROCE % for the quarter that ended in Apr. 2026 was 0.00%.

Sernova Biotherapeutics  (HAM:PSH0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sernova Biotherapeutics ROCE % Related Terms

Sernova Biotherapeutics ROCE % Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics ROCE % Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.06 -65.47 -122.20 -13,603.23 0.00

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:PSH0
28GF Score
Sernova Biotherapeutics Inc HAM:PSH0
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics ROCE % Calculation

Sernova Biotherapeutics's annualized ROCE % for the fiscal year that ended in Oct. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Oct. 2025 )  (A: Oct. 2024 )(A: Oct. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Oct. 2025 )  (A: Oct. 2024 )(A: Oct. 2025 )
=-9.199/( ( (5.023 - 13.356) + (0.469 - 15.228) )/ 2 )
=-9.199/( (-8.333+-14.759)/ 2 )
=-9.199/-11.546
=79.67 %

Sernova Biotherapeutics's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=-5.736/( ( (0.626 - 15.78) + (0.954 - 6.803) )/ 2 )
=-5.736/( ( -15.154 + -5.849 )/ 2 )
=-5.736/-10.5015
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Sernova Biotherapeutics (HAM:PSH0) has a ROCE % of 0.00% as of Apr. 2026.
Is Sernova Biotherapeutics' ROCE % too high?
Sernova Biotherapeutics' current ROCE % is 0.00%. Overall, Sernova Biotherapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' ROCE % compare to VRTX and REGN?
Sernova Biotherapeutics' ROCE % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Sernova Biotherapeutics's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (HAM:PSH0) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Sernova Biotherapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sernova Biotherapeutics (HAM:PSH0), the current ROCE % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
28GF Score

Get the complete analysis for HAM:PSH0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price